FDA Import Refusal AEK-9338523-3/30003/1 — NOVO NORDISK INDIA PRIVATE LIMIT
The FDA refused shipment AEK-9338523-3/30003/1 from NOVO NORDISK INDIA PRIVATE LIMIT (India) on June 29, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 75
Refusal Details
- Date
- June 29, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 75